39082-07-0Relevant articles and documents
Selenolopyrazole derivatives and use thereof as anticancer agents
-
Page/Page column 3-4, (2011/11/13)
The present invention synthesizes a series of selenolo[3,2-c]pyrazole and selenolo[2,3-c]pyrazole derivatives, and discovers their anticancer activity.
Synthesis of 1-benzyl-3-(5-hydroxymethyl-2-furyl)selenolo[3,2-c]pyrazole derivatives as new anticancer agents
Chou, Li-Chen,Huang, Li-Jiau,Hsu, Mei-Hua,Fang, Mei-Chi,Yang, Jai-Sing,Zhuang, Shi-Hong,Lin, Hui-Yi,Lee, Fang-Yu,Teng, Che-Ming,Kuo, Sheng-Chu
experimental part, p. 1395 - 1402 (2010/06/12)
As part of our continuing search for potential anticancer drug candidates among YC-1 analogs, 1, 3-disubstituted selenolo[3,2-c]pyrazole derivatives were synthesized and evaluated for their cytotoxicity against NCI-H226 non-small cell lung cancer and A-498 renal cancer cell lines. Significant cytotoxicity was observed in 3-(5-hydroxymethyl-2-furyl) derivatives (2, 33, 36 and 37). Among them, compound 2 was found to have the most potent activity. The mode of action of compound 2 seems to differ from those of the 175 anticancer agents listed in NCI's standard database and resembles that of YC-1. Thus, we recommend that compound 2 should be developed further as new drug candidate for treatment of non-small cell lung cancer and renal cancer.